Insider Transactions in Q3 2024 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2024
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
648
-6.07%
|
$44,064
$68.52 P/Share
|
|
Sep 13
2024
|
Andrew M. Dahl SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,920
+38.37%
|
-
|
|
Sep 11
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$330,000
$66.77 P/Share
|
|
Sep 11
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Sep 03
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
5,530
-6.37%
|
$381,570
$69.96 P/Share
|
|
Sep 03
2024
|
Catherine M. Szyman CVP, Critical Care |
BUY
Grant, award, or other acquisition
|
Direct |
10,910
+11.16%
|
-
|
|
Aug 20
2024
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,250
-4.09%
|
$86,250
$69.95 P/Share
|
|
Aug 14
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$330,000
$66.08 P/Share
|
|
Aug 14
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Jul 11
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
500
-2.11%
|
$47,000
$94.18 P/Share
|
|
Jul 11
2024
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.07%
|
$22,500
$45.28 P/Share
|
|
Jul 10
2024
|
David T Feinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,308
+50.0%
|
-
|
|
Jul 10
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-9.63%
|
$465,000
$93.29 P/Share
|
|
Jul 10
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.78%
|
$225,000
$45.28 P/Share
|
|
Jul 07
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
82
-0.04%
|
$7,544
$92.32 P/Share
|
|
Jul 07
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-1.74%
|
$37,720
$92.32 P/Share
|
|
Jul 07
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-0.34%
|
$23,736
$92.32 P/Share
|